• LAST PRICE
    8.1100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    7.8200/ 1
  • Ask / Lots
    8.2800/ 5
  • Open / Previous Close
    8.0200 / 8.1100
  • Day Range
    Low 7.9500
    High 8.2481
  • 52 Week Range
    Low 3.4800
    High 25.5700
  • Volume
    609,458
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 8.17
TimeVolumeTGTX
09:32 ET186058.065
09:33 ET29628.04
09:35 ET63568.14
09:37 ET68468.17
09:39 ET52548.21
09:42 ET82618.16
09:44 ET35118.1025
09:46 ET78898.14
09:48 ET25328.11
09:50 ET25008.09
09:51 ET24548.09
09:53 ET12008.12
09:55 ET23498.105
09:57 ET5138.11
10:00 ET21818.11
10:02 ET22178.085
10:04 ET44228.12
10:06 ET16468.1608
10:08 ET24378.14
10:09 ET9008.18
10:11 ET75008.2
10:13 ET46208.17
10:15 ET29808.17
10:18 ET20668.15
10:20 ET20838.15
10:22 ET11008.14
10:24 ET35508.155
10:26 ET13008.14
10:27 ET226658.0945
10:29 ET25088.075
10:31 ET25338.1
10:33 ET47748.08
10:36 ET17008.09
10:38 ET13538.09
10:40 ET79718.075
10:42 ET16578.07
10:44 ET21008.06
10:45 ET73928.07
10:47 ET82398.05
10:49 ET22198.05
10:51 ET31548.0287
10:54 ET13218.05
10:56 ET7458.04
10:58 ET10168.08
11:00 ET19508.07
11:02 ET10008.08
11:03 ET5008.0843
11:05 ET46248.09
11:07 ET11208.08
11:09 ET15008.06
11:12 ET15868.0508
11:14 ET24858.045
11:16 ET26988.04
11:18 ET25668.02
11:20 ET14188.015
11:21 ET3008.04
11:23 ET16458.045
11:25 ET28298.03
11:27 ET4008.06
11:30 ET124508.04
11:32 ET13488.02
11:34 ET10078.005
11:36 ET49948.0199
11:38 ET13008.02
11:39 ET6008.015
11:41 ET66657.98
11:43 ET81447.98
11:45 ET5007.975
11:48 ET65367.975
11:50 ET90947.965
11:52 ET72907.975
11:54 ET18577.97
11:56 ET31657.985
11:57 ET6007.975
11:59 ET11207.975
12:01 ET62647.96
12:03 ET30007.975
12:06 ET105237.96
12:08 ET56387.97
12:10 ET155767.975
12:12 ET117998.035
12:14 ET18608.07
12:15 ET17198.04
12:17 ET18718.02
12:19 ET23418.03
12:21 ET5008.035
12:24 ET3008.04
12:26 ET17758.055
12:28 ET23578.045
12:30 ET10338.045
12:32 ET10278.045
12:33 ET24348.035
12:35 ET13008.035
12:37 ET37278.05
12:39 ET8008.05
12:42 ET14998.07
12:44 ET29198.07
12:46 ET41228.08
12:48 ET41668.105
12:50 ET68868.11
12:51 ET28008.065
12:53 ET23008.085
12:55 ET47708.095
12:57 ET71648.09
01:00 ET1194388.11
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTGTX
TG Therapeutics Inc
1.2B
-4.5x
---
United StatesACRS
Aclaris Therapeutics Inc
1.2B
-13.6x
---
United StatesCINC
CinCor Pharma Inc
1.2B
-11.2x
---
United StatesIMGO
Imago BioSciences Inc
1.2B
-19.5x
---
United StatesMDGL
Madrigal Pharmaceuticals Inc
1.1B
-4.2x
---
United StatesBLU
BELLUS Health Inc
1.1B
-13.1x
---
As of 2022-11-27

Company Information

TG Therapeutics, Inc. (TG) is a fully integrated, commercial stage biopharmaceutical company, which is focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. Its pipeline candidates include TG-1501 (Cosibelimab), TG-1701 (BTK inhibitor), TG-1801 (anti-CD47/anti-CD19 bispecific monoclonal antibody). Its UKONIQ (umbralisib) is developed for the treatment of adult patients with relapsed or refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed or refractory follicular lymphoma. It has three programs in Phase III development for the treatment of patients with relapsing forms of multiple sclerosis and patients with chronic lymphocytic leukemia and several investigational medicines in Phase I clinical development. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.

Contact Information

Headquarters
2 Gansevoort Street, 9Th FloorNEW YORK, NY, United States 10014
Phone
212-554-4484
Fax
212-554-4531

Executives

Chairman of the Board, President, Chief Executive Officer
Michael Weiss
Chief Financial Officer, Treasurer, Corporate Secretary
Sean Power
Lead Independent Director
Laurence Charney
Independent Director
Yann Echelard
Independent Director
Kenneth Hoberman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.2B
Revenue (TTM)
$5.0M
Shares Outstanding
145.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.17
EPS
$-1.78
Book Value
$1.66
P/E Ratio
-4.5x
Price/Sales (TTM)
234.6
Price/Cash Flow (TTM)
---
Operating Margin
-4,651.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.